Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 76 publications
hTERT Expression, Regulation, and Prognostic Significance in Pediatric Medulloblastoma.
Journal: bioRxiv : the preprint server for biology
Published: May 18, 2026
hTERT Expression, Regulation, and Prognostic Significance in Pediatric Medulloblastoma.
Journal: bioRxiv : the preprint server for biology
Published: May 18, 2026
Phase I Study of 131I-Metaiodobenzylguanidine With Dinutuximab ± Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 23, 2025
Accelerating Drug Development for Neuroblastoma: Consensus Statement From the Third Neuroblastoma Drug Development Strategy Forum.
Journal: Pediatric blood & cancer
Published: February 26, 2025
Sequential Combination of Unfavorable Histology, Followed by Clinical Stage M, Defines High-Risk Neuroblastoma: A Report from the Children's Oncology Group.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 18, 2025
Extracellular Matrix Topography Drives Adrenergic to Mesenchymal Transition in Neuroblastoma.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: January 21, 2025
Multicellular tumor-stromal interactions recapitulate aspects of therapeutic response and human oncogenic signaling in a 3D disease model for H3K27M-altered DIPG.
Journal: Oncogene
Published: December 10, 2024
Comparison of human pluripotent stem cell differentiation protocols to generate neuroblastoma tumors.
Journal: Scientific reports
Published: July 06, 2024
Identification and Characterization of Chemotherapy-Resistant High-Risk Neuroblastoma Persister Cells.
Journal: Cancer discovery
Published: February 05, 2024
CD33-CD123 IF-THEN Gating Reduces Toxicity while Enhancing the Specificity and Memory Phenotype of AML-Targeting CAR-T Cells.
Journal: Blood cancer discovery
Published: December 12, 2023
Nuclear factor-κB activation by transforming growth factor-β1 drives tumour microenvironment-mediated drug resistance in neuroblastoma.
Journal: British journal of cancer
Published: October 13, 2023
Last Updated: 09/26/2026